| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 09/18/2007 | CA2236648C Sulfatation of estrogen mixtures |
| 09/12/2007 | EP1832598A2 Therapeutic treatment of androgen receptor driven conditions |
| 09/12/2007 | EP1831239A1 A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid lambda-lactone and key-intermediates for this process |
| 09/11/2007 | US7268241 Therapy for hormone sensitive diseases; contraceptives |
| 09/07/2007 | WO2007068434A3 Medicament based on a monoester of steroids with long chain fatty acids |
| 09/05/2007 | CN101029069A Kaide glycoside 3-O-beta-Cima glycoside in white fleece-flower root and its use |
| 08/30/2007 | WO2007008474A3 3 -ester prodrugs of estradiol |
| 08/30/2007 | US20070203102 Estrogen Receptor Modulators |
| 08/29/2007 | EP1824805A1 Method for preparation of organofluoro compounds in alcohol solvents |
| 08/29/2007 | EP1423125B1 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
| 08/28/2007 | US7262023 synthesis of steroids by hydroxylation and oxidation with use of microoganisms; biosynthesis |
| 08/22/2007 | CN1332973C Extraction process of conjugated female hormone |
| 08/15/2007 | EP0752874B1 Enhanced virus-mediated dna transfer |
| 08/09/2007 | WO2007024338A3 3 -ester prodrugs of ethynylestradiol |
| 08/08/2007 | CN101014610A 15beta-substituted steroids having selective estrogenic activity |
| 08/08/2007 | CN101012264A Method of synthesizing pig ectohormone |
| 08/07/2007 | CA2271657C Androgen as a male contraceptive and non-contraceptive androgen replacement |
| 08/07/2007 | CA2263904C Process to obtain oestrogens from mare's urine |
| 08/01/2007 | CN101010332A Process for the preparation of estrone and/or estradiol-derivates |
| 07/31/2007 | US7250408 Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility |
| 07/31/2007 | CA2260584C Androsterone derivatives for inhibiting dna binding of ap-1 and airway smooth muscle proliferation |
| 07/26/2007 | DE102005059222A1 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen 11ß-Benzaldoximderivate of D-Homoestra-4,9-dien-3-ones |
| 07/25/2007 | EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/25/2007 | EP1042352B1 Androgenic steroid compounds and a method of making and using the same |
| 07/25/2007 | CN101003560A Midbody of steroid, and application |
| 07/19/2007 | WO2007080951A1 Process for production of steroids |
| 07/18/2007 | EP1807118A2 Steroid analogs and characterization and treatment methods |
| 07/12/2007 | US20070161779 Estrogen Extraction From Pregnant Animal Urine |
| 07/11/2007 | EP1805201A1 15b-substituted steroids having selective estrogenic activity |
| 07/11/2007 | CN1995058A 6 alpha-bromo- androstane-4-ene-3,17-dione high efficient synthesis method |
| 07/11/2007 | CN1325507C 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/05/2007 | WO2007074776A1 Method for purification of substances contaminated with organic chemicals |
| 07/05/2007 | WO2007073908A1 A process for the isolation of pharmacologically active principles of vegetable and animal origin |
| 07/05/2007 | CA2634958A1 A process for the isolation of pharmacologically active principles of vegetable and animal origin |
| 07/04/2007 | CN1324041C Preparation method of tibolong crystal type I |
| 07/03/2007 | US7238338 Antioxidant, such as ethanol and/or ascorbic acid added to the radiolabeled compound during its preparation and/or storage, allows retention of biological or chemical activity of the radiohalogen-labeled compound such as nucleosides, nucleotides |
| 06/26/2007 | US7235655 Processes to prepare eplerenone |
| 06/26/2007 | US7235650 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 06/26/2007 | US7235540 Anticancer agents; substantially free of steroid contaminants having estrogenic or carcinogenic effects; |
| 06/26/2007 | CA2179753C Method of converting hydroxyl groups into corresponding fluoro compounds |
| 06/21/2007 | WO2007068434A2 Medicament based on a monoester of steroids with long chain fatty acids |
| 06/21/2007 | US20070142307 Hormone replacement therapy; menopause therapy; sexual disorders, vasomotor symptoms, atrophic vaginitis, and osteoporosis. |
| 06/21/2007 | US20070141109 Local Deliver of 17-Beta Estradiol for Preventing Vascular Intimal Hyperplasia and for Improving Vascular Endothelium Function after Vascular Injury |
| 06/14/2007 | US20070135400 Estradiol derivatives |
| 06/14/2007 | US20070135375 Sulfamoyl sulfonate prodrugs |
| 06/14/2007 | US20070135358 Steroid modified solatrioses |
| 06/13/2007 | EP1794175A1 Process for the preparation of estrone and/or estradiol-derivates |
| 06/13/2007 | CN1321128C Preparation method of 9 alpha, 11 alpha-epoxy-17 beta-hydroxy-3-oxy-17 alpha pregn-4-olefine-7 alpha, 21-diformic acid gammalactone 7-methyl ester |
| 06/07/2007 | US20070129332 Processes to prepare eplerenone |
| 06/06/2007 | EP1791854A2 Methods of treating disorders having a component of mercury toxicity |
| 06/06/2007 | EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| 06/06/2007 | CN1976944A 雌激素受体调节剂 Estrogen receptor modulators |
| 05/31/2007 | US20070123704 7alpha-biscarbonyl-substituted steroid compounds |
| 05/31/2007 | US20070123500 Prodrugs of ERbeta-selective substances, processes for their preparation and pharmaceutical compositions comprising these compounds |
| 05/31/2007 | DE102005057225A1 New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
| 05/31/2007 | DE102005057224A1 New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/29/2007 | US7225083 Determination antagonist, moderators; three-dimensional models |
| 05/24/2007 | US20070117780 Process to Prepare Eplerenone |
| 05/23/2007 | EP1196427B1 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 05/23/2007 | CN1968960A 雌激素受体调节剂 Estrogen receptor modulators |
| 05/23/2007 | CN1317293C Technique for synthesizing the exemestane |
| 05/22/2007 | US7220733 Separating conjugated estrogens from pregnant mares' urine, using pervaporation on pore-free silicone membrane; hormone replacement therapy |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2171460C Preparation for substitution therapy, containing at least one progestogen and at least one extrogen |
| 05/16/2007 | CN1962680A 20-hydroxy-16 alpha- bromo-steroid compound, synthesis method and its uses |
| 05/16/2007 | CN1962679A 16-bromo-3-p-chlorobenzoxy-5- androst-17-one compound and its synthesis method |
| 05/16/2007 | CN1962678A Adamantane acid andrusol derivatives |
| 05/15/2007 | CA2134961C Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
| 05/10/2007 | US20070106072 7a-Furyl or thienyl-substituted steroid compounds |
| 05/10/2007 | US20070105886 Steroidal compounds for inhibiting steroid sulphatase |
| 05/09/2007 | CN1314701C New etonogestrel esters |
| 05/08/2007 | US7214808 Reacting 3,3-dimethoxy-5alpha, 10alpha-epoxy-estr-9(11)-en-17-one with an active methylene reagent in an inert solvent into an intermediate, regio or stereoselective cleavage of 17-spiroepoxy group |
| 05/03/2007 | WO2007049672A1 Process for production of steroid compound |
| 05/03/2007 | US20070100140 used to prepare eplerenone; intermediates |
| 05/03/2007 | US20070099880 Estrogen receptor modulators |
| 05/03/2007 | US20070099876 Target directed chemotherapy of tumours of the sexual organs |
| 05/02/2007 | EP1330467B1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 05/01/2007 | US7211246 Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand) |
| 04/25/2007 | CN1311833C Inhibition of the growth factor dependency of tumor cells |
| 04/24/2007 | USRE39592 Solid composition for implantation into an animal of 17 beta -acetoxyestra-4,9,11-trien-3-one and Estra-1,3,5(10)-trien-3,17 beta -diol with 75:25-DL-lactide-glycolide Copolymer; biodegradable polymer |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2073855C Glycoalkaloids for controlling cellular autophagy |
| 04/19/2007 | US20070088042 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088013 6-Methyloxaalkyl exemestane compounds such as 6-Methyloxamethyl exemestane used to inhibit growth and proliferation of cancer cells; anticarcinogenic agents; antiproliferative agents |
| 04/19/2007 | US20070087960 Treating hepatitis C virus infections; antivirals have low toxicity to the host; inhibit Flaviviridae polymerase |
| 04/18/2007 | EP1773862A1 Estrogen receptor modulators |
| 04/18/2007 | EP1773754A2 Methods and compositions for treating cancer |
| 04/18/2007 | EP1187846B1 11beta long-chain substituted estratrienes, method for their production, pharmaceutical preparations containing said 11beta long-chain substituted estratrienes, and their use for producing medicaments |
| 04/17/2007 | US7205287 Platinum complexes having antitumor activity |
| 04/12/2007 | WO2007041564A2 (s)-6-methyloxaalkyl exemestane compounds and related methods of use |
| 04/11/2007 | EP1771462A2 A process for the preparation of 7-alpha-alkylated 19-norsteroids |
| 04/11/2007 | EP1771461A2 Novel 2-substituted estra-1,3,5(10)-trien-17-ones used in the form of inhibitors of 17beta-hydroxysteroiddehydrogenase of type 1 |
| 04/10/2007 | CA2333985C Testosterone derivative |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1769799A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 04/04/2007 | EP1307205B1 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |